Activities, Bill Numbers and Titles
|
|
Client: Pharmaceutical Research and Manufacturers of America, Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $1,419.23
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1272
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
804
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
790
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
1915
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussed issues related to Prescription Drug Pricing
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|